Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study-Reference-Cited by-同舟云学术

Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study

Published:2021-10 Issue:4 Volume:160 Page:1255-1270
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Wang Meng-Ting,Lai Jyun-Heng,Huang Ya-Ling,Liou Jun-Ting,Cheng Shih-Hsuan,Lin Chen Wei,Pan Hsueh-Yi,Hsu Yu-Juei,Tsai Chen-Liang

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference50 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary;Vogelmeier;Am J Respir Crit Care Med,2017

2. Once-daily single-inhaler triple versus dual therapy in patients with COPD;Lipson;N Engl J Med,2018

3. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial;Papi;Lancet,2018

4. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial;Vestbo;Lancet,2017

5. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease;Siddiqui;Am J Respir Crit Care Med,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2024-10

2. A clinician’s guide to single vs multiple inhaler therapy for COPD;Expert Review of Respiratory Medicine;2024-07-02

3. A preliminary study of optimal treatment response rates in patients undergoing hepatic arterial infusion chemotherapy combined with molecular targeting and immunotherapy;Frontiers in Immunology;2024-04-10

4. Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis;COPD: Journal of Chronic Obstructive Pulmonary Disease;2024-04-04

5. The clinical characteristics and outcomes of different inhaled therapies in chronic obstructive pulmonary disease patients with frequent cough;Annals of Medicine;2023-12-12